Metastatic Colorectal Carcinoma Clinical Trials
3 recruiting trials for Metastatic Colorectal Carcinoma. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGPhase 2NCT05733000
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With...
This phase II trial tests how well CPI-613 (devimistat) in combination with hydroxychloroquine (HCQ) and 5-fluorouracil (5-FU) or gemcitabine works in patients with solid tumors...
Sponsor: Northwestern UniversityEnrolling: 941 location
RECRUITINGPhase 1NCT05803382
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for...
This phase I trial tests the safety, side effects, and best dose of ZEN003694 in combination with the usual treatment with capecitabine in treating patients with cancer that has...
Sponsor: National Cancer Institute (NCI)Enrolling: 3020 locations
RECRUITINGPhase 1NCT05759923
First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients with...
The goal of this clinical trial is to learn if the OATD-02 administration (orally) in monotherapy is safe and has the pharmacodynamic potential to restore and enhance tumour...
Sponsor: Molecure S.A.Enrolling: 403 locations